Prologue Medicines logo
VerifiedBiotechnology Research

Prologue Medicines

Prologue is designing powerful new medicines by unlocking the viral proteome. The company’s state-of-the-art DELVE™ Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by Flagship Pioneering in 2021.

7-day free trial · no credit card

Verified contacts

20

available on Kipplo

LinkedIn employees

22

11 to 50 range

Open roles

no listings

Distinct roles

8

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 20 verified contacts at Prologue Medicines

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

20 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Prologue Medicines

8 distinct titles indexed · top 8 shown.

  • 2research associate
  • 2vp, head of platform (june 2025)
  • 1()
  • 1director, head of data science
  • 1principal scientist, discovery biology
  • 1senior bioinformatics data engineer
  • 1senior computational structural biologist data scientist
  • 1senior scientist ii, ai & computational science

Sign up to unlock all 20 contacts at Prologue Medicines

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 20 verified contacts at Prologue Medicines

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Prologue Medicines | Kipplo Discover